Acuta Capital Partners’s Verve Therapeutics VERV Stock Holding History

Acuta Capital Partners’s Portfolio VERV Stock Details VERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$744K	Buy
2024 Q4	$904K	Buy
2024 Q3	$707K	Buy